FDA MedWatch Safety AlertsOriginal article
UPDATE: Hintermann Series H3 Total Ankle Replacement Has a Higher-Than-Expected Risk of Device Failure: FDA Safety Communication
RegulatoryHintermann Series H3 Total Ankle ReplacementNegative
AI Analysis
Summary
FDA issued a safety communication regarding the Hintermann Series H3 Total Ankle Replacement system, noting higher-than-expected risk of device failure. The communication includes recommendations for both patients and healthcare providers.
Outcome Details
FDA safety communication regarding higher-than-expected risk of device failure
Importance:7/10
Sentiment:
-0.80
device safetyFDA communicationorthopedicsmedical devicedevice failure risk
Read the original article
Published by FDA MedWatch Safety Alerts on June 3, 2026 4:00 AM